Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Foa

Showing results (41-50 of 175) with videos related to

Pageof 18
Sort By:
Journal of Cellular Physiology|January 1, 1985
Release of hemopoietic factors by normal human T cell lines with either suppressor or helper activityL Lanfrancone, D Ferrero, E Gallo, et al.
Clinical Immunology and Immunopathology|February 1, 1983
T lymphocytes in B-cell chronic lymphocytic leukemia: characterization by monoclonal antibodies and correlation with Fc receptorsG Semenzato, A Pezzutto, R Foa, et al.
Nouvelle Revue Francaise D'Hematologie|November 1, 1974
[Statistical study of distribution of nuclear pores in lymphoid cells (author's transl)]C Foa, R Foa, H Bazin, et al.
Nouvelle Revue Francaise D'Hematologie|May 1, 1973
[Morphological erythroblast and erythrocyte abnormalities during the course of proliferative diseases of the myeloid tissue]R Muratore, R Foa, R Follana, et al.
British Journal of Haematology|May 12, 1998
Cytotoxic effectors activated by low-dose IL-2 plus IL-12 lyse IL-2-resistant autologous acute myeloid leukaemia blastsA Vitale, A Guarini, R Latagliata, et al.
Haematologica|February 1, 1980
Colony stimulating activity (CSA) in human adult and cord blood. Interaction between leucocytes and plasmaR Foa', M Aglietta, L Sacchetti, et al.
Leukemia|November 1, 1992
Has IL2 a role in the management of minimal residual disease for acute leukemia?R Foa, G Meloni, A Guarini, et al.
Leukemia & Lymphoma|July 28, 2016
Use of the MTT Chemosensitivity Assay in B-Cell Chronic Lymphocytic LeukemiaR Foa, F Vischia, M Pini, et al.
Cancer Gene Therapy|April 19, 2000
Interleukin-2 gene-transduced human leukemic cells induce major histocompatibility complex-restricted and -unrestricted anti-leukemic effectors in mixed lymphocyte-tumor culturesA Cignetti, A Guarini, A Gillio Tos, et al.
European Journal of Haematology|August 1, 1990
Cytokines and DIC in acute leukaemiaA Guarini, L Gugliotta, A Bianchi, et al.
Pageof 18

Showing results (41-50 of 175) with videos related to

Sort By:
Pageof 18
Journal of Cellular Physiology|January 1, 1985
Release of hemopoietic factors by normal human T cell lines with either suppressor or helper activityL Lanfrancone, D Ferrero, E Gallo, et al.
Clinical Immunology and Immunopathology|February 1, 1983
T lymphocytes in B-cell chronic lymphocytic leukemia: characterization by monoclonal antibodies and correlation with Fc receptorsG Semenzato, A Pezzutto, R Foa, et al.
Nouvelle Revue Francaise D'Hematologie|November 1, 1974
[Statistical study of distribution of nuclear pores in lymphoid cells (author's transl)]C Foa, R Foa, H Bazin, et al.
Nouvelle Revue Francaise D'Hematologie|May 1, 1973
[Morphological erythroblast and erythrocyte abnormalities during the course of proliferative diseases of the myeloid tissue]R Muratore, R Foa, R Follana, et al.
British Journal of Haematology|May 12, 1998
Cytotoxic effectors activated by low-dose IL-2 plus IL-12 lyse IL-2-resistant autologous acute myeloid leukaemia blastsA Vitale, A Guarini, R Latagliata, et al.
Haematologica|February 1, 1980
Colony stimulating activity (CSA) in human adult and cord blood. Interaction between leucocytes and plasmaR Foa', M Aglietta, L Sacchetti, et al.
Leukemia|November 1, 1992
Has IL2 a role in the management of minimal residual disease for acute leukemia?R Foa, G Meloni, A Guarini, et al.
Leukemia & Lymphoma|July 28, 2016
Use of the MTT Chemosensitivity Assay in B-Cell Chronic Lymphocytic LeukemiaR Foa, F Vischia, M Pini, et al.
Cancer Gene Therapy|April 19, 2000
Interleukin-2 gene-transduced human leukemic cells induce major histocompatibility complex-restricted and -unrestricted anti-leukemic effectors in mixed lymphocyte-tumor culturesA Cignetti, A Guarini, A Gillio Tos, et al.
European Journal of Haematology|August 1, 1990
Cytokines and DIC in acute leukaemiaA Guarini, L Gugliotta, A Bianchi, et al.
Pageof 18